Postoperative molecular diagnosis confirmed IDH wild-type, absence of 1p/19q co-deletion, and presence of a pTERT mutation, consistent with GBM, IDH wild-type, and WHO CNS grade 4. Here, IDH2 is linked to glioblastoma.